Taking the Wraps Off Drug Safety Data From Clinical Trials

Current Rules Allow Data to be Kept Secret, Hinder Discovery of Dangerous Side Effects
For Immediate Release.
Boston, MA — For years, pharmaceutical companies have sought to restrict public access to drug safety data collected in clinical trials on the basis that it is proprietary information, arguing that competitors could use that information in the development of [...]